A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2011
12/01/2011	US20110293576 Mesenchymal stromal cell populations and methods of isolating and using same
12/01/2011	CA2800521A1 Fused imidazole derivative
11/2011
11/30/2011	EP2390250A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/30/2011	EP2276756B1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
11/30/2011	EP1806136B1 Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy
11/30/2011	EP1392823B1 Desaturase genes and uses thereof
11/30/2011	EP1392360B1 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/30/2011	CN102264707A 新型双环型杂环化合物 Novel bicyclic heterocyclic compounds
11/30/2011	CN102260266A 吡唑并[3,4-d]嘧啶酮类化合物及其在制备磷酸二酯酶Ⅸ抑制剂中的应用 Pyrazolo [3,4-d] pyrimidine-ketone compounds and its application in the preparation of phosphoric acid Ⅸ PDE inhibitor
11/30/2011	CN102260252A 可用于治疗细菌感染的新噁唑烷酮 New oxazolidinone useful for treating bacterial infections
11/30/2011	CN102260250A (-)多沙唑嗪甲磺酸盐Ⅳ型结晶、其制备方法及用途 (-) Doxazosin mesylate Ⅳ type crystals, their preparation and use
11/30/2011	CN102260249A (-)多沙唑嗪甲磺酸盐Ⅱ型结晶、其制备方法及用途 (-) Doxazosin mesylate type Ⅱ crystallization, their preparation and use
11/30/2011	CN102258768A 重组人白介素15在治疗肾癌病症药物中的应用 Recombinant human interleukin-15 in the treatment of kidney disease drug application
11/30/2011	CN102258731A 一种治疗尿频的中药组合物 A treatment for urinary medicine composition
11/30/2011	CN102258721A 一种五谷养生中药及其制法 One kind of grain health medicine Jiqizhifa
11/30/2011	CN102258718A 一种配制酒及其制备方法和用途 One kind of wine preparation and its preparation method and use
11/30/2011	CN102258701A 一种补肾口服液 One kind of kidney Oral
11/30/2011	CN102258649A 一种治疗小儿尿频的中药组合物 A treatment for children with urinary medicine composition
11/30/2011	CN102258629A 一种治疗前列腺炎的中药组合物 A treatment for prostatitis herbal composition
11/30/2011	CN102258615A 炎宁胶囊及其制备方法 Yan Ning capsule and its preparation method
11/30/2011	CN102258597A 一种前列通瘀片的制备工艺 Preparation of a piece of Qianlietongyu
11/30/2011	CN102258557A 一种治疗前列腺增生的药物 A drug treatment of benign prostatic hyperplasia
11/30/2011	CN102258543A 一种灵芝炮制方法 Ganoderma lucidum processing methods
11/30/2011	CN102258520A 一种预防或治疗化疗引发的膀胱炎的药物组合物 A method of preventing or treating chemotherapy induced cystitis pharmaceutical composition
11/30/2011	CN102258509A 大黄酸或大黄酸类化合物与精氨酸的复合物在制备治疗糖尿病并发症药物中的应用 Rhubarb rhubarb acid or acids and arginine compound used in the preparation of a medicament for the treatment of diabetic complications
11/30/2011	CN102258496A 溴吡斯的明缓释片剂及其制备方法 Ming-release tablets pyridostigmine bromide and its preparation method
11/30/2011	CN102258492A 溴新斯的明缓释片剂及其制备方法 Ming-release tablets bromine neostigmine and its preparation method
11/30/2011	CN102258469A 一种奥昔布宁醇质体组合物及其制备方法 One kind of oxybutynin Ethosomes composition and its preparation method
11/30/2011	CN101953899B 一种益肾壮阳的中药组合物 One kind of kidney yang of Chinese medicine composition
11/30/2011	CN101773542B 一种治疗前列腺疾病的药物及其制备方法 And preparation of a drug for the treatment of prostate disease
11/30/2011	CN101716141B 一种氟罗沙星注射液及其制备方法 An injection Fleroxacin fluoride and its preparation method
11/30/2011	CN101708010B 克无踪与2甲4氯钠和碳酸氢铵三元复配制成的除草水剂 Gramoxone and MCPA sodium bicarbonate three yuan complex formulated into herbicidal agent
11/30/2011	CN101653582B 一种治疗肾结石的药物 A treatment for kidney stones drugs
11/30/2011	CN101444476B 新微球和其生产方法 The new microspheres and its production method
11/29/2011	US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067569 Splice-region antisense composition and method
11/29/2011	US8067444 Administering to a diabetic patient with a baseline serum creatinine concentration of =/>1.3 mg/dL an amount of pyridoxamine or its chloride to limit renal disease progression and/or diabetic complications to slow the increase in serum creatinine levels in the patient relative to placebo; ACE inhibitors
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067392 Compositions and methods for treatment of mitochondrial diseases
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067039 Extract of plant Dendrobii caulis and preparing process thereof
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2453843C Substituted 4-aminocyclohexanol derivatives
11/24/2011	WO2011146036A1 Medicinal multi-organ protection agent for treating conditions caused by cellular dysfunction
11/24/2011	WO2011145642A1 Pharmaceutical composition containing solifenacin
11/24/2011	WO2011145307A1 Adiponectin production accelerating composition
11/24/2011	WO2011145019A1 Improved process for diphenylpropylamine derivatives
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288134 Composition and method for treating fibrosis
11/24/2011	US20110288129 Amide derivatives as trpv1 antagonists
11/24/2011	US20110288118 Pharmaceutical composition comprising solifenacin
11/24/2011	US20110288103 Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives
11/24/2011	US20110288093 Compounds, Compositions, and Methods Comprising Pyridazine Sulfonamide Derivatives
11/24/2011	US20110288092 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
11/24/2011	US20110288087 Fused ring compound and use thereof
11/24/2011	US20110288060 apparatus and process for producing crystals
11/24/2011	US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System
11/24/2011	US20110288015 Treatment of renal dysfunction and multiple myeloma using pacap compounds
11/24/2011	US20110288012 Nutrition composition
11/24/2011	US20110288011 Peptide therapeutic conjugates and uses thereof
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011	US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
11/24/2011	US20110287100 Galenic Formulations of Organic Compounds
11/24/2011	US20110287065 Nanoparticulate cinacalcet compositions
11/24/2011	US20110287018 Methods of Treating Interstitial Cystitis
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	CA2799942A1 Pharmaceutical composition containing solifenacin
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP1569937B1 C-6 modified indazolylpyrrolotriazines
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	EP1385527B2 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
11/23/2011	CN1993467B Gene related with prostate disease and encoding polypeptides and its application
11/23/2011	CN102250800A Oxalic acid degrading bacterium NJODL1 and application thereof
11/23/2011	CN102250799A Oxalate-degrading strain NJODE1 and application thereof
11/23/2011	CN102250738A Health-care wine and production process thereof
11/23/2011	CN102250737A Wine with health-care effect
11/23/2011	CN102250736A Health-care medicated wine and preparation method thereof
11/23/2011	CN102250732A Tussah female moth beautifying wine for women, and production process thereof
11/23/2011	CN102250189A Glycyrrhetic acid derivative with 1, 12-diene-3-ketone skeleton, its preparation method and medicinal uses
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN102247567A Traditional Chinese medicine preparation for effectively treating urethritis
11/23/2011	CN102247566A Medicament for treating prostatitis and preparation method thereof
11/23/2011	CN102247553A Medical composition for treating chronic renal failure
11/23/2011	CN102247542A Medicine for treating diabetes and kidney disease, cataract and other diabetic complications
11/23/2011	CN102247541A Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma
11/23/2011	CN102247540A Renal function health-care wine
11/23/2011	CN102247515A Traditional Chinese medicine compound preparation used for treating diabetic nephropathy, and preparation method thereof
11/23/2011	CN102247506A Chinese medicinal composition for treating chyluria
11/23/2011	CN102247487A Chinese medicinal preparation and use thereof
11/23/2011	CN102247484A Formulas of kidney strengthening traditional Chinese medicine external washing powder and effervescent tablet, and their preparation methods
11/23/2011	CN102247394A Medical application of Harpagoside ingredient

1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 562